179.00 €
PT-141 Nasal Spray features Bremelanotide, a synthetic peptide studied for its interaction with melanocortin receptors involved in sexual function and neuroendocrine signaling.
Originally developed from alpha-MSH, PT-141 has been explored in clinical and research settings for its central nervous system activity and receptor-specific mechanisms.
Delivered intranasally for non-invasive administration, this formulation is commonly used in investigational studies examining peptide-based modulation of behavioral and physiological pathways.
Unlike many nasal applications on the market that deliver low doses of PT-141, often providing minimal efficacy, our advanced formulation provides 1.25 mg per spray. This higher concentration ensures a more potent and effective dose, allowing for quicker and more reliable results. Its ease of use and fast absorption make it ideal for on-demand application.
PT-141 Nasal Spray features Bremelanotide, a synthetic peptide studied for its interaction with melanocortin receptors involved in sexual function and neuroendocrine signaling.
Originally developed from alpha-MSH, PT-141 has been explored in clinical and research settings for its central nervous system activity and receptor-specific mechanisms.
Delivered intranasally for non-invasive administration, this formulation is commonly used in investigational studies examining peptide-based modulation of behavioral and physiological pathways.
Unlike many nasal applications on the market that deliver low doses of PT-141, often providing minimal efficacy, our advanced formulation provides 1.25 mg per spray. This higher concentration ensures a more potent and effective dose, allowing for quicker and more reliable results. Its ease of use and fast absorption make it ideal for on-demand application.
